Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q1 FY27 results · Apr–Jun 2026
Acutaas Chemicals reported revenue from operations of ₹329.67 crore (up 59.1% from Q1 FY26) and net profit of ₹74.99 crore (up 70.4% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 329.67 | 207.24 | +59.1% | 432.75 | −23.8% |
| Other income | 1.80 | 15.94 | −88.7% | 11.11 | −83.8% |
| Total income | 331.48 | 223.17 | +48.5% | 443.86 | −25.3% |
| Profit before tax | 103.91 | 58.08 | +78.9% | 183.80 | −43.5% |
| Net profit for the period | 74.99 | 44.01 | +70.4% | 134.28 | −44.2% |
| Attributable to shareholders of the company | 74.26 | 44.29 | +67.7% | 131.76 | −43.6% |
| EPS, basic (₹) | 9.07 | 5.41 | +67.7% | 16.09 | −43.6% |
| Net margin (%) | 22.7 | 21.2 | 31.0 |
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 322.41 | 205.97 | +56.5% | 421.77 | −23.6% |
| Other income | 4.48 | 16.02 | −72.1% | 14.55 | −69.2% |
| Total income | 326.89 | 221.99 | +47.3% | 436.32 | −25.1% |
| Profit before tax | 104.02 | 58.93 | +76.5% | 185.86 | −44.0% |
| Net profit for the period | 75.90 | 44.65 | +70.0% | 137.07 | −44.6% |
| EPS, basic (₹) | 9.27 | 5.45 | +70.1% | 16.74 | −44.6% |
| Net margin (%) | 23.5 | 21.7 | 32.5 |
Consolidated
- Filed with BSE
- 24 Jul 2026, 16:28 IST
- Board meeting
- 24 Jul 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 24 Jul 2026, 16:28 IST
- Board meeting
- 24 Jul 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE